Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Allow to absorb fully
By Route of Administration (Daily Injectable, Weekly Injectable, and Oral Small-Molecule): The weekly injectable segment held a share of 90.80% in 2025, driven by convenience, improved patient adherence, and strong clinical outcomes
These local reactions are generally minor and resolve quickly
Positioned as a potential physiological regulator, LR3 IGF-I may govern [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts, demonstrating effective stimulation of glucose transport in bone-derived osteoblastic (PyMS) cells even at markedly lower concentrations than insulin
US$ 29.09
US$ 21.57
US$ 23.34
US$ 20.90
US$ 27.88
US$ 25.37
